Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors

International Journal of Hematology

Volumn 77, Issue 3, 2003, Pages 259-262

  Mori, Naoki ^a,b   Yang, Rong ^a   Kawamata, Norihiko ^a   Miller, Carl W ^a   Mizoguchi, Hideaki ^b   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

CDK4 gene; Cell cycle; Leukemia; Mutation; Tumor

Indexed keywords

CYCLIN DEPENDENT KINASE 4; GENOMIC DNA; PROTEIN P16;

ARTICLE; CELL LINE; GENE MUTATION; GENE SEQUENCE; HUMAN; LEUKEMIA; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOLID TUMOR; TWO HYBRID SYSTEM;

EID: 0141457814     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983783     Document Type: Article

References (13)

1. Hirama T, Koeffler HP. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood. 1995;86:841-854.
2. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 1995;269:1281-1284.
3. INK4a binding domain of CDK4 in familial melanoma. Nature Genet. 1996;12:97-99.
4. Fitzgerald MG, Harkin DP, Silva-Arrieta S, et al. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci U S A. 1996;93:8541-8545.
5. Qari MH, Khalil SH, Kambouris M, Meyer BF. Mutation of p16, p21 or cyclin dependent kinase 4 is rare in acute lymphoblastic leukaemia. Br J Haematol. 1998;103:467-472.
6. Einsiedel HG, Taube T, Beyermann B, et al. Absence of mutations in the CDKN2 binding site of CDK4 in childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2001;40:413-417.
7. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989;5:874-879.
8. INK4A and its interaction with CDK4. Biochem Biophy Res Commun. 1997;218:254-259.
9. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704-707.
10. De Bondt HL, Rosenblatt J, Jancarik J, Jones HD, Morgan DO, Kim S. Crystal structure of cyclin-dependent kinase 2. Nature. 1993;363:595-602.
11. Weinberg RA. Tumor suppressor genes. Science. 1991;254:1138-1146.
12. Guldberg P, Kirkin AF, Gronbaek K, thor Straten P, Ahrenkiel V, Zeuthen J. Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma. Int J Cancer. 1997;72:780-783.
13. Coleman KG, Wautlet BS, Morrissey D, et al. Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J Biol Chem. 1997;272:18869-18874.